Q3 2019 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to the Navidea's Biopharmaceuticals Third Quarter 2019 Earnings Call. (Operator Instructions) I will now turn the conference over to your host, Jed Latkin, you may begin, Mr. Latkin.
Thank you, Jerry. Good afternoon, and welcome, everyone, to Navidea's Third Quarter 2019 Earnings Call. I am Jed Latkin, Chief Executive Officer of Navidea Biopharmaceuticals. This call will cover Navidea's financial operating results for the third quarter of 2019, which ended on September 30, 2019, along with a discussion of goals and milestones for the remainder of 2019 and into 2020. Following our prepared remarks, we will open up the conference call to a question-and-answer session.
With me on our call today is our Chief Medical Officer, Dr. Mike Rosol; and our Director of Finance and Administration, Erika Gibson. But before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call may be considered forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |